EUVIMED · CrossrefZeitschrift
Molecular Genetics and Metabolism
ISSN 1096-7192 · Elsevier BV
Neueste Artikel
Clinical and sociodemographic characterization of acute hepatic porphyria patients in the first Colombian registry
Evaluating the feasibility and diagnostic performance of a multi-tier newborn screening algorithm for X-linked adrenoleukodystrophy in Denmark
Mass spectrometry measurements of glycosaminoglycans to assess disease-modifying treatments for the mucopolysaccharidoses: Methodological considerations
Infusion-associated reactions during enzyme replacement therapy in late-onset Pompe disease: a systematic review and proposed management algorithm
Clinical impact of the CPT1A p.P479L ‘Arctic variant’: Evidence for benefit, risk, and gaps in understanding
Regional newborn screening for Gaucher disease in Kumamoto and Fukuoka Prefectures, Japan: an updated report and long-term outcomes of screen-identified patients
Reduced renal function, age and sex influence the measured level of glycosaminoglycans (GAGs) and could lead to diagnostic misinterpretation
Computational tools for biomarker identification in inborn errors of metabolism: A rapid systematic review
Carcinoembryonic antigen (CEA) is a useful screening biomarker for inherited glycosylphosphatidylinositol deficiencies
Phosphodiesterase-5 inhibition as an off-label therapy in mitochondrial disease
FGF21 elevation is a biomarker of citrin deficiency and its metabolic dysregulation in pediatric patients
C-type lectin 10A [CD301] mRNA is upregulated in symptomatic acute intermittent porphyria and decreases after heme treatment
Current management of biotinidase deficiency following newborn screening in Italy: evidence from a clinical nationwide survey
CRISPR screening in neurodegeneration and lysosomal biology: Uncovering disease mechanisms and genetic modifiers
Predicted deficiency of the GTP cyclohydrolase I feedback regulatory protein (GFRP): a disorder of dynamic tetrahydrobiopterin homeostasis
Porphyria cutanea tarda: cutaneous manifestations and management
Muscle ATP homeostasis and exercise: insights from ADSS1 myopathy
Hyperinflammatory syndromes in primary mitochondrial disease: A three-center case series and focused review
Single-center real-world experience with givosiran for management of acute intermittent porphyria
Intravenous hemin for prevention of frequent attacks of acute hepatic porphyria - a double-blind placebo controlled pilot study
Clinical characteristics and management of patients with mucopolysaccharidosis II in the United States enrolled in the Hunter Outcome Survey
Masculinizing hormone therapy in latent AIP. First case in Argentina
Gallbladder involvement in metachromatic leukodystrophy: a systematic review and comparison of American and European surveillance recommendations
Empowering children and young people with Erythropoietic Protoporphyria (EPP)/X-linked Erythropoietic Protoporphyria (XLP): Outcomes of attending a disease-specific residential camp
Longitudinal audiological findings in mild to moderate Mucopolysaccharidosis type II and potential impact of inner ear dysfunction following blood-brain barrier-penetrating enzyme therapy
Clinical, biochemical, and genetic perspectives in hepatic glycogen storage diseases: HEPA-GSD study
Corrigendum to ‘FGF21 elevation is a biomarker of citrin deficiency and its metabolic dysregulation in pediatric patients’ [Mol. Genet. Metab., Volume 149, Issue 3, November 2026, 110262]
Age, metabolites, and diagnostic discrimination in mitochondrial disease
A quantitative disorder–phenotype atlas of inherited metabolic disorders reveals shared symptom spaces and group-specific hotspots
The burden of an ultra-rare inherited skin disorder: Congenital erythropoietic porphyria
EUVIMED